Stamaril (yellow fever vaccine): Reviews and patient testimonials

Stamaril

STAMARIL is indicated for active immunization against yellow fever in persons:

• travelling to, passing through or living in an endemic area,

• travelling to any country that requires an International Certificate of Vaccination for entry (which may or may not depend on the previous itinerary),

• handling potentially infectious materials (e.g. laboratory personnel).

See Sections 4.2, 4.3 and 4.4 regarding the minimum age for vaccination of children under special circumstances and guidance for vaccination of other specific patient populations.

In order to comply with vaccine regulations and to be officially recognized, yellow fever vaccines must be administered in an approved World Health Organization (WHO) vaccination centre and registered on an International Certificate of Vaccination. The validity period of this Certificate is established according to International Health Regulations (IHR) recommendations, and starts 10 days after primary vaccination and immediately after re-vaccination (see Section 4.2).

Molecule: yellow fever vaccine